A phenotypic screening assay for modulators of huntingtin-induced transcriptional dysregulation.
about
Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.Advances in huntington disease drug discovery: novel approaches to model disease phenotypes.Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity.
P2860
A phenotypic screening assay for modulators of huntingtin-induced transcriptional dysregulation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A phenotypic screening assay f ...... transcriptional dysregulation.
@ast
A phenotypic screening assay f ...... transcriptional dysregulation.
@en
A phenotypic screening assay f ...... transcriptional dysregulation.
@nl
type
label
A phenotypic screening assay f ...... transcriptional dysregulation.
@ast
A phenotypic screening assay f ...... transcriptional dysregulation.
@en
A phenotypic screening assay f ...... transcriptional dysregulation.
@nl
prefLabel
A phenotypic screening assay f ...... transcriptional dysregulation.
@ast
A phenotypic screening assay f ...... transcriptional dysregulation.
@en
A phenotypic screening assay f ...... transcriptional dysregulation.
@nl
P2093
P2860
P356
P1476
A phenotypic screening assay f ...... transcriptional dysregulation.
@en
P2093
Andrea Caricasole
Cesare Federico
Daniela Diamanti
Freddy Heitz
Giulia Lazzeroni
Lara Rossini
Letizia Magnoni
Luisa Massai
Salvatore La Rosa
Tiziana Benicchi
P2860
P304
P356
10.1177/1087057113484802
P577
2013-04-05T00:00:00Z